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Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards 
breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa 
and SiHa)  
ABSTRACT 
Thymoquinone (TQ) has been shown to exhibit antitumor properties. Thymoquinone-loaded 
nanostructured lipid carrier (TQ-NLC) was developed to improve the bioavailability and 
cytotoxicity of TQ. This study was conducted to determine the cytotoxic effects of TQ-NLC 
on breast cancer (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). 
TQ-NLC was prepared by applying the hot high pressure homogenization technique. The 
mean particle size of TQ-NLC was 35.66 ± 0.1235 nm with a narrow polydispersity index 
(PDI) lower than 0.25. The zeta potential of TQ-NLC was greater than −30 mV. Polysorbate 
80 helps to increase the stability of TQ-NLC. Differential scanning calorimetry showed that 
TQ-NLC has a melting point of 56.73°C, which is lower than that of the bulk material. The 
encapsulation efficiency of TQ in TQ-NLC was 97.63 ± 0.1798% as determined by HPLC 
analysis. TQ-NLC exhibited antiproliferative activity towards all the cell lines in a dose-
dependent manner which was most cytotoxic towards MDA-MB-231 cells. Cell shrinkage 
was noted following treatment of MDA-MB-231 cells with TQ-NLC with an increase of 
apoptotic cell population (P < 0.05). TQ-NLC also induced cell cycle arrest. TQ-NLC was 
most cytotoxic towards MDA-MB-231 cells. It induced apoptosis and cell cycle arrest in the 
cells. 
